Vivos Therapeutics VVOS
NASDAQ VVOS
$0.15 0.00 (-1.66%)
As of: Sep 30, 2026 · 11:59 AM EDT

Vivos Therapeutics (VVOS) EBIT Margin (2020 - 2026)

Updated

Vivos Therapeutics (VVOS) reported EBIT Margin of -93.63% for Q2 2026, up 33.72 percentage points from -127.36% a year earlier and up 35.04 percentage points from the prior quarter.

Analysis

Vivos Therapeutics (VVOS) EBIT Margin (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Vivos Therapeutics' EBIT Margin came in at -107.92%, down 9.03 percentage points year-over-year; for FY2025, it was -114.05%, down 39.73 percentage points from FY2024.

  • EBIT Margin has a five-year change of -21.90 percentage points (FY2020 to FY2025).
  • By year, EBIT Margin came in at -74.32% in FY2024 (+51.00 pp), -125.32% in FY2023 (+30.89 pp), -156.21% in FY2022 (-35.50 pp) and -120.71% in FY2021 (-28.56 pp).
  • Five-year quarterly EBIT Margin spans a low of -182.19% in Q1 2022 and a high of -47.76% in Q2 2024.
  • Year over year, EBIT Margin gained in four of the last eight quarters, with an average year-over-year change of -7.88 percentage points.
  • The high point for year-over-year EBIT Margin in five years was Q2 2024 (a gain of 85.29 percentage points); the low point was Q4 2025 (a drop of 91.01 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -128.67% (Q1 2026), -166.89% (Q4 2025) and -69.79% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 13.44%
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 33.60%
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 18.08%
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 25.18%
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 21.65%
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 13.31%
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 29.48%
10 Vivos Therapeutics 1.89 Mn -7.32 Mn 2.95 Mn -93.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -93.63%
Mar 31, 2026 -128.67%
Dec 31, 2025 -166.89%
Sep 30, 2025 -69.79%
Jun 30, 2025 -127.36%
Mar 31, 2025 -129.91%
Dec 31, 2024 -75.88%
Sep 30, 2024 -68.52%
Jun 30, 2024 -47.76%
Mar 31, 2024 -110.70%
Dec 31, 2023 -127.25%
Sep 30, 2023 -110.27%
Jun 30, 2023 -133.05%
Mar 31, 2023 -129.76%
Dec 31, 2022 -153.49%
Sep 30, 2022 -127.34%
Jun 30, 2022 -166.44%
Mar 31, 2022 -182.19%
Dec 31, 2021 -168.66%
Sep 30, 2021 -121.05%
API Access

Vivos Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=VVOS&period=max&api_key=YOUR_API_KEY